Follow The Filings

TBBK Bancorp

Financials, filed as BANCORP ORD (EQUITY), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by TBBK's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TBBK insider trades
  • $1.3M bought by 3 insiders
  • $1.2M sold by 4 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Martin Egan Chief Accounting Officer
    Sale
    $220K 3,057 shares at $72.03 9.2% of stake
    Traded Aug 6 Filed Aug 6
  2. Matthew Cohn Director
    Buy
    $149K 2,500 shares at $59.52
    Traded May 1–4 Filed May 5
  3. Erika R Caesar EVP and General Counsel
    Sale
    $269K 4,470 shares at $60.28 12% of stake
    Traded Apr 29 Filed Apr 30
  4. Maria Wainwright EVP & Chief Marketing Officer
    Sale
    $506K 8,400 shares at $60.24 25% of stake
    Traded Apr 28 Filed Apr 30
  5. Ryan Harris EVP Head of Fintech Solutions
    Sale
    $239K 4,500 shares at $53.18 2.9% of stake
    Traded Mar 13 Filed Mar 16
  6. Dominic C Canuso CFO
    Buy
    $111K 2,000 shares at $55.26 +12% to stake
    Traded Feb 27 Filed Mar 2
  7. Matthew Cohn Director
    Buy
    $65K 1,080 shares at $60.18 +68% to stake
    Traded Feb 10–12 Filed Feb 12
  8. Dominic C Canuso CFO
    Buy
    $183K 3,000 shares at $60.93 +23% to stake
    Traded Feb 6–10 Filed Feb 10
  9. Mark E Tryniski Director
    Buy
    $301K 5,000 shares at $60.23 +36% to stake
    Traded Feb 4 Filed Feb 5
  10. Dominic C Canuso CFO
    Buy
    $220K 3,500 shares at $62.89 New stake
    Traded Nov 12–14 Filed Nov 14, 2025
  11. Matthew Cohn Director
    Buy
    $226K 3,645 shares at $62.12 New stake
    Traded Nov 6–7 Filed Nov 10, 2025

Also filed in the last 12 months, not counted as buying or selling: 18 stock grants, 8 share withholdings for taxes, 7 gifts, and 1 other transaction.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
8-K 2.02,7.01,9.01
8-K/A 5.02,9.01
8-K 2.05,5.02,7.01,9.01
SCHEDULE 13G/A —
10-Q
8-K 7.01,9.01
SCHEDULE 13G —
8-K 2.02,7.01,9.01
8-K 5.07
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
8-K 2.02,7.01
DEF 14A
DEFA14A
SCHEDULE 13G/A —
10-K

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue — $116.8M $141.15M
Net income $192.3M $217.54M $228.21M
Net margin * — 186.3% 161.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total assets $7.71B $8.73B $9.35B
Total equity $807.28M $789.78M $689.8M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $186.72M $227.65M $265.01M
Cash from investing $0.416B -$1.51B -$1.06B
Cash from financing -$452.37M $812.74M $341.7M
Net change in cash * $149.9M -$467.97M -$457.47M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.